Literature DB >> 7789289

Hypertension in pregnancy. Practical management recommendations.

E D Gallery1.   

Abstract

Hypertension is a common and potentially serious complication of human pregnancy. It can be a marker of underlying maternal disease processes aggravated by pregnancy, or it can be directly related to the pregnancy (pre-eclampsia). It is associated with increased risks of fetal growth retardation and, if severe, can cause both maternal and fetal problems. The risks to both mother and neonate can be reduced by appropriate supervision and therapy. Close monitoring of maternal and fetal welfare will help to determine the optimum time for delivery. Maternal hypertension should be controlled with agents considered to be well tolerated in pregnancy. Following the index pregnancy, all patients with early and/or severe hypertension should be investigated for an underlying cause. Provided that there is clinical resolution of acute pregnancy-related hypertension, investigations are usually postponed until at least 3 months following delivery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789289     DOI: 10.2165/00003495-199549040-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  12 in total

1.  Salt in pregnancy.

Authors:  M ROBINSON
Journal:  Lancet       Date:  1958-01-25       Impact factor: 79.321

Review 2.  Pregnancy-induced hypertension: pathogenesis and management.

Authors:  M A Brown
Journal:  Aust N Z J Med       Date:  1991-04

3.  Medical problems in pregnancy.

Authors: 
Journal:  Med Clin North Am       Date:  1989-05       Impact factor: 5.456

4.  Proceedings from the International Symposium on Renal Function and Disease in Pregnancy. Chicago, Illinois, September 19-20, 1986.

Authors: 
Journal:  Am J Kidney Dis       Date:  1987-04       Impact factor: 8.860

5.  Pre-eclampsia: more than pregnancy-induced hypertension.

Authors:  J M Roberts; C W Redman
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

6.  Atenolol in essential hypertension during pregnancy.

Authors:  L Butters; S Kennedy; P C Rubin
Journal:  BMJ       Date:  1990-09-22

Review 7.  Endothelial function in normal and pre-eclamptic pregnancy: a hypothesis.

Authors:  G G Zeeman; G A Dekker; H P van Geijn; A A Kraayenbrink
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1992-01-31       Impact factor: 2.435

8.  Management of hypertension in pregnancy: executive summary. Australasian Society for the Study of Hypertension in Pregnancy.

Authors: 
Journal:  Med J Aust       Date:  1993-05-17       Impact factor: 7.738

9.  Fetal outcome in trial of antihypertensive treatment in pregnancy.

Authors:  C W Redman
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

10.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-03-12       Impact factor: 79.321

View more
  2 in total

1.  Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination.

Authors:  H Jeong; S Choi; J W Song; H Chen; J H Fischer
Journal:  Xenobiotica       Date:  2008-01       Impact factor: 1.908

Review 2.  Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.

Authors:  Dylan van de Vusse; Paola Mian; Sam Schoenmakers; Robert B Flint; Willy Visser; Karel Allegaert; Jorie Versmissen
Journal:  Eur J Clin Pharmacol       Date:  2022-09-15       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.